BEGIN:VCALENDAR
VERSION:2.0
X-WR-CALNAME;VALUE=TEXT:Professor Michael Fischbach
PRODID:-//Harvard events data//EN
BEGIN:VEVENT
UID:event_1443148_0
SUMMARY:Professor Michael Fischbach
DESCRIPTION:<p>	<!--break--></p><p>	Professor Michael Fischbach, Stanford University. <strong>Title: </strong><span><span>Understanding and manipulating immune modulation by the microbiome<br><br><strong>Abstract: </strong>Certain members of the commensal microbiota elicit a potent T cell response upon colonization. In this talk, I will describe two recent projects from my research group that share the goal of characterizing and manipulating anti-commensal immunity. In the first project, we explore the functional properties of colonist-induced T cells by engineering the skin bacterium Staphylococcus epidermidis to express tumor antigens anchored to secreted or cell-surface proteins. Upon colonization, engineered S. epidermidis elicits tumor-specific T cells that circulate, infiltrate local and metastatic lesions, and exert cytotoxic activity, showing that the immune response to a colonist can be redirected against a target of therapeutic interest by expressing a target-derived antigen in a commensal. In the second, we colonize germ-free mice with a complex defined community (&gt;100 bacterial strains) and profile T cell responses to each strain individually. We find that T cell recognition of Firmicutes is focused on a widely conserved cell-surface antigen, opening the door to new therapeutic strategies in which colonist-specific immune responses are rationally altered or redirected.</span></span><br> </p><p>	<drupal-media data-entity-type="media" data-entity-uuid="d2407b24-8bb0-495b-8f89-d3abbea7bdf5" alt="Professor Michael Fischbach at CCB on YouTube" data-view-mode="hwp_medium"></drupal-media></p>
LOCATION:Pfizer Lecture Hall
STATUS:CONFIRMED
DTSTART:20221027T201500Z
DTEND:20221027T211500Z
END:VEVENT
END:VCALENDAR